ATE299704T1 - Warmgeformte feste arzneizusammensetzung zur gesteuerten wirkstoffabgabe von perindopril - Google Patents
Warmgeformte feste arzneizusammensetzung zur gesteuerten wirkstoffabgabe von perindoprilInfo
- Publication number
- ATE299704T1 ATE299704T1 AT01989653T AT01989653T ATE299704T1 AT E299704 T1 ATE299704 T1 AT E299704T1 AT 01989653 T AT01989653 T AT 01989653T AT 01989653 T AT01989653 T AT 01989653T AT E299704 T1 ATE299704 T1 AT E299704T1
- Authority
- AT
- Austria
- Prior art keywords
- perindopril
- hot
- medicinal composition
- controlled delivery
- formed solid
- Prior art date
Links
- IPVQLZZIHOAWMC-QXKUPLGCSA-N perindopril Chemical compound C1CCC[C@H]2C[C@@H](C(O)=O)N(C(=O)[C@H](C)N[C@@H](CCC)C(=O)OCC)[C@H]21 IPVQLZZIHOAWMC-QXKUPLGCSA-N 0.000 title 1
- 229960002582 perindopril Drugs 0.000 title 1
- 239000007787 solid Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Cardiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0017013A FR2818550B1 (fr) | 2000-12-26 | 2000-12-26 | Composition pharmaceutique solide thermoformable pour la liberation controle de perindopril |
| PCT/FR2001/004133 WO2002051407A1 (fr) | 2000-12-26 | 2001-12-21 | Composition pharmaceutique solide thermoformable pour la liberation controlee de perindopril |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE299704T1 true ATE299704T1 (de) | 2005-08-15 |
Family
ID=8858188
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01989653T ATE299704T1 (de) | 2000-12-26 | 2001-12-21 | Warmgeformte feste arzneizusammensetzung zur gesteuerten wirkstoffabgabe von perindopril |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US20040115227A1 (cs) |
| EP (1) | EP1345605B1 (cs) |
| JP (1) | JP2004518666A (cs) |
| KR (1) | KR100542473B1 (cs) |
| CN (1) | CN1218696C (cs) |
| AR (1) | AR031972A1 (cs) |
| AT (1) | ATE299704T1 (cs) |
| AU (1) | AU2002228118B2 (cs) |
| BR (1) | BR0116536A (cs) |
| CA (1) | CA2432896A1 (cs) |
| CZ (1) | CZ297796B6 (cs) |
| DE (1) | DE60112117T2 (cs) |
| DK (1) | DK1345605T3 (cs) |
| EA (1) | EA005139B1 (cs) |
| ES (1) | ES2244672T3 (cs) |
| FR (1) | FR2818550B1 (cs) |
| HU (1) | HU230249B1 (cs) |
| MX (1) | MXPA03005792A (cs) |
| NO (1) | NO333590B1 (cs) |
| NZ (1) | NZ526405A (cs) |
| PL (1) | PL203836B1 (cs) |
| PT (1) | PT1345605E (cs) |
| SK (1) | SK286920B6 (cs) |
| WO (1) | WO2002051407A1 (cs) |
| ZA (1) | ZA200304405B (cs) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SK50252005A3 (sk) * | 2005-03-22 | 2006-10-05 | Vúlm, A.S. | Farmaceutický prípravok obsahujúci perindopril erbumín, spôsob jeho prípravy a stabilizácie |
| BRPI0615607A2 (pt) * | 2005-08-30 | 2011-05-24 | Lek Pharmaceuticals | composição farmacêutica compreendendo perindopril ou seus sais |
| CA2846446A1 (en) * | 2011-08-30 | 2013-03-07 | Universiteit Gent | Multi-layered release formulation |
| RU2670447C2 (ru) * | 2016-11-17 | 2018-10-23 | Общество с ограниченной ответственностью "Изварино Фарма" | Пероральная твердая лекарственная форма с микофенольной кислотой или ее солью для использования в качестве иммунодепрессанта для лечения или предупреждения отторжения трансплантата органа или ткани и способ ее получения |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5002776A (en) * | 1983-12-22 | 1991-03-26 | Elan Corporation, Plc | Controlled absorption diltiazem formulations |
| DE4138513A1 (de) * | 1991-11-23 | 1993-05-27 | Basf Ag | Feste pharmazeutische retardform |
| US5589499A (en) * | 1992-11-25 | 1996-12-31 | Weth; Gosbert | Dopaminergic agents for the treatment of cerebral and peripheral blood flow disorders |
| US5965161A (en) * | 1994-11-04 | 1999-10-12 | Euro-Celtique, S.A. | Extruded multi-particulates |
| DE19724696A1 (de) * | 1997-06-12 | 1998-12-24 | Hexal Ag | Pharmazeutische Zubereitung mit drei Pelletarten |
| GB9910773D0 (en) * | 1999-05-11 | 1999-07-07 | West Pharm Serv Drug Res Ltd | Novel single unit coated dosage forms that can be used to minimise the effect of food on the absorption of drugs from the gastrointestinal tract |
| FR2795326B1 (fr) * | 1999-06-28 | 2001-08-31 | Adir | Composition pharmaceutique solide thermoformable a liberation controlee |
-
2000
- 2000-12-26 FR FR0017013A patent/FR2818550B1/fr not_active Expired - Fee Related
-
2001
- 2001-12-21 JP JP2002552552A patent/JP2004518666A/ja active Pending
- 2001-12-21 PT PT01989653T patent/PT1345605E/pt unknown
- 2001-12-21 AU AU2002228118A patent/AU2002228118B2/en not_active Ceased
- 2001-12-21 WO PCT/FR2001/004133 patent/WO2002051407A1/fr active IP Right Grant
- 2001-12-21 SK SK943-2003A patent/SK286920B6/sk not_active IP Right Cessation
- 2001-12-21 HU HU0302524A patent/HU230249B1/hu not_active IP Right Cessation
- 2001-12-21 CA CA002432896A patent/CA2432896A1/fr not_active Abandoned
- 2001-12-21 PL PL361663A patent/PL203836B1/pl unknown
- 2001-12-21 DK DK01989653T patent/DK1345605T3/da active
- 2001-12-21 US US10/451,937 patent/US20040115227A1/en not_active Abandoned
- 2001-12-21 KR KR1020037008655A patent/KR100542473B1/ko not_active Expired - Fee Related
- 2001-12-21 EA EA200300664A patent/EA005139B1/ru not_active IP Right Cessation
- 2001-12-21 CN CNB018213723A patent/CN1218696C/zh not_active Expired - Fee Related
- 2001-12-21 AT AT01989653T patent/ATE299704T1/de active
- 2001-12-21 CZ CZ20032008A patent/CZ297796B6/cs not_active IP Right Cessation
- 2001-12-21 BR BR0116536-4A patent/BR0116536A/pt not_active IP Right Cessation
- 2001-12-21 DE DE60112117T patent/DE60112117T2/de not_active Expired - Lifetime
- 2001-12-21 NZ NZ526405A patent/NZ526405A/xx not_active IP Right Cessation
- 2001-12-21 EP EP01989653A patent/EP1345605B1/fr not_active Expired - Lifetime
- 2001-12-21 MX MXPA03005792A patent/MXPA03005792A/es active IP Right Grant
- 2001-12-21 ES ES01989653T patent/ES2244672T3/es not_active Expired - Lifetime
- 2001-12-26 AR ARP010106028A patent/AR031972A1/es not_active Application Discontinuation
-
2003
- 2003-06-05 ZA ZA200304405A patent/ZA200304405B/en unknown
- 2003-06-16 NO NO20032738A patent/NO333590B1/no not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE303131T1 (de) | Zusammensetzungen zur nasalen verabreichung | |
| DE60126321D1 (de) | Gelsystem zur ocularen verabreichung von arzneimitteln | |
| DE50206657D1 (de) | Pharmazeutische zusammensetzung zur behandlung von multiple sklerose | |
| DE60239648D1 (de) | Pharmazeutische Zusammensetzungen zur Behandlung von Asthma | |
| NO20015175L (no) | Farmasöytisk sammensetning | |
| DE60220661D1 (de) | Transdermales pflaster zur verabreichung von fentanyl | |
| FI991485L (fi) | Uusi farmaseuttinen koostumus | |
| NO20006630D0 (no) | Farmasöytisk sammensetning for behandlingen av diabetes | |
| EE05020B1 (et) | Glburiidi ravimkoostis | |
| DE60019556D1 (de) | 2-amino-benzoxazinonderivate zur behandlung von fettleibigkeit | |
| DE60115418D1 (de) | Mikroinfusionsvorrichtung zur verabreichung von medikamenten | |
| IS5665A (is) | Lyfjafræðileg þrýstiúða samsetning | |
| EE200200357A (et) | Ravimaine suurenenud kontsentratsioone andvad farmatseutilised kompositsioonid | |
| DE60019555D1 (de) | 2-oxy-benzoxazinonderivate zur behandlung von fettleibigkeit | |
| PT1242087E (pt) | Composicoes farmaceuticas | |
| DK1395242T3 (da) | Flydende farmaceutisk sammensætning | |
| DE50004965D1 (de) | Inhibitorkomposition zur Stabilisierung von radikalisch polymerisierbaren Substanzen | |
| DE60131760D1 (de) | Vorrichtung zur verabreichung von physiologisch aktiven wirkstoffen in pulverform | |
| ID29262A (id) | Komposisi farmasi | |
| DE60318831D1 (de) | System zur abgabe von anästhetika | |
| ID27201A (id) | Komposisi farmasi | |
| DE60211183D1 (de) | Pharmazeutische zusammensetzung enthaltend lumiracoxib | |
| PT1239832E (pt) | Composicoes farmaceuticas | |
| DE60037258D1 (de) | System zur verwaltung des endpunktschlages | |
| DE50108168D1 (de) | Transdermales therapeutisches system zur abgabe von lerisetron |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1345605 Country of ref document: EP |